American Airlines has approved the use of Envirotainer RLP and RAP medical containers in its operations, which will enable the carrier to meet increasing demand for life-saving medicines which require temperature-control in transit.
Envirotainer is a specialist in secure cold-chain solutions for the shipment of pharmaceuticals, and American Airlines says using its technologies will be able to better support sensitive shipments in a highly regulated market while providing pharma shippers with secure and sustainable cold-chain solutions.
Envirotainer says its Releye range of containers helps airlines and shippers to meet the strictest standards in pharmaceutical air freight. Its advanced containers were created with a focus on control, monitoring, autonomy, and reliability to minimise the likelihood of valuable product loss that could negatively impact patients’ health outcomes.
“The Releye RLP and RAP containers are reliably designed for transporting critical Life Sciences and Pharmaceutical shipments, making it a perfect addition to our current cold-chain network,” said Eric Mathieu, head of customer experience for American Airlines Cargo.
